ARYS
At-Risk Youth Study. Street-involved youth aged 14 to 26 who use unregulated drugs other than cannabis.
ARYS answers are pooled and turned into research that shapes services and policy. Here is some of what we have found.
Opioid agonist therapy (OAT) cuts daily street opioid use among youth and young adults who use drugs.
But young people on OAT do not see improvements in other important areas, like getting services, housing and staying out of jail.
More than two thirds of ARYS participants are not on OAT.
Over two thirds of young people who start methadone later stop.
Young people report low interest in starting buprenorphine-naloxone (Suboxone).
681 people from VIDUS, ACCESS and ARYS who used street opioids (down, fentanyl or heroin) were asked between June 2021 and November 2022.
74%
said yes to: "If you could be prescribed any medical-grade opioid you wanted, would any make you use street opioids less?"
Out of 504 people.
| Opioid | Said it was their opioid of choice | Got a prescription for it in the past 6 months |
|---|---|---|
| Medical-grade heroin (diacetylmorphine) | 43% | 6% |
| Fentanyl patches | 11% | 13% |
| Fentanyl powder | 11% | 0% |
Most people said their preferred prescription could help, but very few were actually getting it. Safer supply should keep being tried and studied as a way to prevent overdose deaths.
ARYS started in 2005. It is an ongoing study that follows young people who use unregulated drugs in Vancouver. It works alongside two other BCCSU studies, VIDUS and ACCESS.
At-Risk Youth Study. Street-involved youth aged 14 to 26 who use unregulated drugs other than cannabis.
Vancouver Injection Drug Users Study. HIV-negative adults who inject drugs.
AIDS Care Cohort to evaluate Exposure to Survival Services. HIV-positive adults who use unregulated drugs other than cannabis.